AlphaStocks
3.4
Weak

PTC Therapeutics, Inc. (PTCT)

As of Sep 20, 2026, PTC Therapeutics, Inc. (PTCT) scores 3.4/10 on AlphaStocks' five-model composite, #152 of 168 Health Care stocks.

Health Care / Pharmaceuticals

S&P SmallCap 600

$65.41

Scores poorly across most models. Proceed with caution.

Weak

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#152out of 168 in Health Care

Is PTC THERAPEUTICS, INC. a Good Investment in 2026?

PTC THERAPEUTICS, INC. (PTCT) scores 3.4 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model is the most favorable, rating PTC THERAPEUTICS, INC. as Neutral. However, the Greenblatt Magic Formula model rates it Caution — Earnings yield -5.0% · ROC -36%. PTC THERAPEUTICS, INC. ranks #152 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E8.5ROE-23.6Market Cap5B

Valuation

Trades at 8x earnings — near sector median of 30x.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

3/9

Buffett

Caution

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Limited Data

Growth rate vs price (PEG)

Greenblatt

Caution

Earnings yield -5.0% · ROC -36%

Frequently Asked Questions

Is PTC THERAPEUTICS, INC. (PTCT) a good investment?
As of Sep 20, 2026, PTC Therapeutics, Inc. (PTCT) scores 3.4/10 on AlphaStocks' five-model composite, #152 of 168 Health Care stocks. That score is below average, suggesting caution. Trades at 8x earnings — near sector median of 30x.
What is PTC THERAPEUTICS, INC.'s Piotroski F-Score?
PTC THERAPEUTICS, INC.'s Piotroski F-Score status is Neutral. The raw score is 3/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is PTCT overvalued or undervalued?
A precise fair value estimate is not available for PTCT. Trades at 8x earnings — near sector median of 30x.
How does PTCT compare to other Health Care stocks?
PTC THERAPEUTICS, INC. ranks #152 out of 168 stocks in the Health Care sector, placing it in the top 90% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about PTCT?
AlphaStocks evaluates PTCT using five proven investment models. Piotroski: Neutral; Buffett: Caution; Graham: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 3.4/10.

Similar Stocks

Compare PTCT with

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer